Scheduling

As the Food and Drug Administration (Fda) carries out a scientific overview into marijuana that will advise its federal scheduling position, leading officers at the company say they are months absent from releasing a regulatory evaluation for hemp-dependent solutions like CBD. Fda has confronted major criticism in the latest many […]